论文部分内容阅读
Ⅱ型糖尿病患者常伴有血液流变学异常,这种异常被认为是糖尿病大血管病变的病理基础。本文观察了一组Ⅱ型糖尿病人口服降糖药治疗前后不同时间内的血液流变学变化,以探讨其血流变学异常与病情两者之间的关系。对象及方法一、观察对象由内分泌专科医生按WHO 糖尿病诊断标准新近诊断未经治疗的Ⅱ型糖尿病人56例,其中男女各28例,年龄22～74岁,平均56岁,病程1～12月,平均3月。并发症:白内障2人,周围神经炎3人,高血压8人,冠心病6人。二、方法本组病例均在饮食控制的基础上加用口服降糖药治疗,其中用 D860者19例,优降糖18例,达美康8例,降糖灵11例。于治
Patients with type 2 diabetes are often associated with abnormalities in blood rheology, which is considered as the pathological basis for macrovascular disease in diabetes. This article observed a group of type 2 diabetes oral hypoglycemic agents before and after treatment of hemorheology changes at different times to explore the relationship between hemorheology abnormalities and the condition of the two. Subjects and methods First, the object of observation by the endocrine specialist WHO diagnostic criteria for diabetes newly diagnosed untreated type Ⅱ diabetes in 56 patients, including 28 men and women of each age ranged from 22 to 74 years, mean 56 years of age, duration of January to December , Average March. Complications: 2 cataracts, peripheral neuritis 3 people, 8 people with hypertension, 6 people with coronary heart disease. Second, the methods of this group of patients are based on diet plus oral hypoglycemic agents, of which 19 cases with D860, glyburide in 18 cases, up to the United States in 8 cases, hypoglycemic in 11 cases. In the rule